20-068 - Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
Status: openA Multicenter, Longitudinal, Open-label, Single-arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod
Patients with Relapsing Multiple Sclerosis
Contact Us
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by phone at +1 (251) 665-8375 or by email at dlwilliams@health.southalabama.edu.
Description
This is a phase 3 clinical trial with ozanimod in relapsing forms of multiple sclerosis. The primary objective is to determine if and how cognition changes when taking ozanimod. This is a 3 year study with approximately 4 visits per year.
